Sign in
4

Changes in Ownership

IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001250853-16-000159

Options or other derivatives

  • CFO acquired 200,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Henderson Molly · CFO

Table II: Derivative

2 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2016-06-01 Grant or award : show line 1 in the form Stock Option +150,000 $5.87 2026-06-01 150,000 150,000 D
2016-06-10 Grant or award : show line 2 in the form Stock Option +50,000 $7.61 2016-06-10 50,000 50,000 D
Loading xslF345X03/primary_doc.xml…